Biological evaluation of anti-influenza viral activity of semi-synthetic catechin derivatives

Antiviral Research

Volumn 76, Issue 2, 2007, Pages 178-185

  Song, Jae Min ^a   Park, Ki Duk ^a   Lee, Kwang Hee ^a   Byun, Young Ho ^a   Park, Ju Hee ^a   Kim, Sung Han ^b   Kim, Jae Hong ^c   Seong, Baik Lin ^a,d  

^a Yonsei University   (South Korea)

^b Nutrex Technology   (South Korea)

^c Seoul National University   (South Korea)

^d Protheon Incorporated   (South Korea)

Author keywords

Alkyl chain; Catechin derivatives; Hemagglutinin; Influenza virus

Indexed keywords

AMANTADINE; CATECHIN; CATECHIN DERIVATIVE; EPIGALLOCATECHIN; EPIGALLOCATECHIN DERIVATIVE; OSELTAMIVIR; SIALIDASE INHIBITOR; UNCLASSIFIED DRUG; VIRUS HEMAGGLUTININ;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG STRUCTURE; ERYTHROCYTE; IN VITRO STUDY; INFLUENZA VIRUS; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H2N2; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H9N2; INFLUENZA VIRUS B; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; VIRUS ADSORPTION;

AMANTADINE; ANIMALS; CATECHIN; CELL LINE; CHICKENS; DOGS; DRUG EVALUATION, PRECLINICAL; EGGS; HEMAGGLUTINATION INHIBITION TESTS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H2N2 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA A VIRUS, H9N2 SUBTYPE; INFLUENZA B VIRUS; MOLECULAR STRUCTURE; OSELTAMIVIR; PLAQUE ASSAY; STRUCTURE-ACTIVITY RELATIONSHIP; VIRUS ATTACHMENT; VIRUS INTERNALIZATION; VIRUS REPLICATION;

AVIAN INFLUENZA VIRUS; HUMAN INFLUENZA VIRUS; ORTHOMYXOVIRIDAE; SPONDIAS PURPUREA;

EID: 34548716936     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.antiviral.2007.07.001     Document Type: Article

References (33)

1. Bantia S., Arnold C.S., Parker C.D., Upshaw R., and Chand P. Anti-influenza virus activity of peramivir in mice with single intramuscular injection. Antiviral Res. 69 (2006) 39-45
2. Betakova T., Nermut M.V., and Hay A.J. The NB protein is an integral component of the membrane of influenza B virus. J. Gen. Virol. 77 (1996) 2689-2694
3. Drusano G.L., Preston S.L., Smee D., Bush K., Bailey K., and Sidwell R.W. Pharmacodynamic evaluation of RWJ-270201, a novel neuraminidase inhibitor, in a lethal murine model of influenza predicts efficacy for once-daily dosing. Antimicrob. Agents Chemother. 45 (2001) 2115-2118
4. Duff K.C., and Ashley R.H. The transmembrane domain of influenza A M2 protein forms amantadine-sensitive proton channels in planar lipid bilayers. Virology 190 (1992) 485-489
5. Gubareva L.V., Matrosovich M.N., Brenner M.K., Bethell R.C., and Webster R.G. Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus. J. Infect. Dis. 178 (1998) 1257-1262
6. Gubareva L.V., Webster R.G., and Hayden F.G. Comparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants. Antimicrob. Agents Chemother. 45 (2001) 3403-3408
7. Hay A.J., Wolstenholme A.J., Skehel J.J., and Smith M.H. The molecular basis of the specific anti-influenza action of amantadine. EMBO J. 4 (1985) 3021-3024
8. Kajiya K., Hojo H., Suzuki M., Nanjo F., Kumazawa S., and Nakayama T. Relationship between antibacterial activity of (+)-catechin derivatives and their interaction with a model membrane. J. Agric. Food Chem. 52 (2004) 1514-1519
9. Kim C.U., Lew W., Williams M.A., Liu H., Zhang L., Swaminathan S., Bischofberger N., Chen M.S., Mendel D.B., Tai C.Y., Laver W.G., and Stevens R.C. Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity. J. Am. Chem. Soc. 119 (1997) 681-690
10. Kiso M., Mitamura K., Sakai-Tagawa Y., Shiraishi K., Kawakami C., Kimura K., Hayden F.G., Sugaya N., and Kawaoka Y. Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet 364 (2004) 759-765
11. Kumagai A., Nagaoka Y., Obayashi T., Terashima Y., Tokuda H., Hara Y., Mukainaka T., Nishino H., Kuwajima H., and Uesato S. Tumor chemopreventive activity of 3-O-acylated (-)-epigallocatechins. Bioorg. Med. Chem. 11 (2003) 5143-5148
12. Le Q.M., Kiso M., Someya K., Sakai Y.T., Nguyen T.H., Nguyen K.H., Pham N.D., Ngyen H.H., Yamada S., Muramoto Y., Horimoto T., Takada A., Goto H., Suzuki T., Suzuki Y., and Kawaoka Y. Avian flu: isolation of drug-resistant H5N1 virus. Nature 437 (2005) 1108
13. Leikina E., Delanoe-Ayari H., Melikov K., Cho M.S., Chen A., Waring A.J., Wang W., Xie Y., Loo J.A., Lehrer R.I., and Chernomordik L.V. Carbohydrate-binding molecules inhibit viral fusion and entry by crosslinking membrane glycoproteins. Nat. Immunol. 6 (2005) 995-1001
14. Liu S., Lu H., Zhao Q., He Y., Niu J., Debnath A.K., Wu S., and Jiang S. Theaflavin derivatives in black tea and catechin derivatives in green tea inhibit HIV-1 entry by targeting gp41. Biochim. Biophys. Acta 1723 (2005) 270-281
15. Luo G., Colonno R., and Krystal M. Characterization of a hemagglutinin-specific inhibitor of influenza A virus. Virology 226 (1996) 66-76
16. Luo G., Torri A., Harte W.E., Danetz S., Cianci C., Tiley L., Day S., Mullaney D., Yu K.L., Ouellet C., Dextraze P., Meanwell N., Colonno R., and Krystal M. Molecular mechanism underlying the action of a novel fusion inhibitor of influenza A virus. J. Virol. 71 (1997) 4062-4070
17. Nakayama M., Suzuki K., Toda M., Okubo S., Hara Y., and Shimamura T. Inhibition of the infectivity of influenza virus by tea polyphenols. Antiviral Res. 21 (1993) 289-299
18. Nam S., Smith D.M., and Dou Q.P. Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo. J. Biol. Chem. 276 (2001) 13322-13330
19. Park K.D., Lee S.G., Kim S.U., Kim S.H., Sun W.S., Cho S.J., and Jeong do H. Anticancer activity of 3-O-acyl and alkyl-(-)-epicatechin derivatives. Bioorg. Med. Chem. Lett. 14 (2004) 5189-5192
20. Park K.D., Park Y.S., Cho S.J., Sun W.S., Kim S.H., Jung do H., and Kim J.H. Antimicrobial activity of 3-O-acyl-(-)-epicatechin and 3-O-acyl-(+)-catechin derivatives. Planta Med. 70 (2004) 272-276
21. Peter E.L. Flavonoid biocides: phytoalexin analogues from condensed tannins. Phytochemistry 26 (1987) 1617-1621
22. Peter E.L., and Marcia S.P. Flavomoid biocides: structure/activity relations of flavonoid phytoalexin analogues. Phytochemistry 28 (1989) 87-91
23. Pinto L.H., Holsinger L.J., and Lamb R.A. Influenza virus M2 protein has ion channel activity. Cell 69 (1992) 517-528
24. Reid A.H., Taubenberger J.K., and Fanning T.G. The 1918 Spanish influenza: integrating history and biology. Microbes Infect. 3 (2001) 81-87
25. Song J.M., Lee K.H., and Seong B.L. Antiviral effect of catechins in green tea on influenza virus. Antiviral Res. 68 (2005) 66-74
26. Song J.M., and Seong B.L. Tea catechins as a potential alternative anti-infectious agent. Expert Rev. Anti. Infect. Ther. 5 (2007) 497-506
27. Stapleton P.D., Shah S., Hamilton-Miller J.M., Hara Y., Nagaoka Y., Kumagai A., Uesato S., and Taylor P.W. Anti-Staphylococcus aureus activity and oxacillin resistance modulating capacity of 3-O-acyl-catechins. Int. J. Antimicrob. Agents 24 (2004) 374-380
28. Stiver G. The treatment of influenza with antiviral drugs. Can. Med. Assoc. J. 168 (2003) 49-56
29. Thompson C.I., Barclay W.S., and Zambon M.C. Changes in in vitro susceptibility of influenza A H3N2 viruses to a neuraminidase inhibitor drug during evolution in the human host. J. Antimicrob. Chemother. 53 (2004) 759-765
30. Uesato S., Kitagawa Y., Hara Y., Tokuda H., Okuda M., Mou X.Y., Mukainaka T., and Nishino H. Antitumor promoting activities of 3-O-acyl-(-) epigallocatechins. Bioorg. Med. Chem. Lett. 10 (2000) 1673-1675
31. Uesato S., Taniuchi K., Kumagai A., Nagaoka Y., Seto R., Hara Y., Tokuda H., and Nishino H. Inhibitory effects of 3-O-acyl-(+)-catechins on Epstein-Barr virus activation. Chem. Pharm. Bull. (Tokyo) 51 (2003) 1448-1450
32. von Itzstein M., Wu W.Y., Kok G.B., Pegg M.S., Dyason J.C., Jin B., Van Phan T., Smythe M.L., White H.F., Oliver S.W., Colman P.M., Varghese J.N., Ryan D.M., Woods J.M., Bethell R.C., Hotham V.J., Cameron J.M., and Penn C.R. Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature 363 (1993) 418-423
33. Weis W., Brown J.H., Cusack S., Paulson J.C., Skehel J.J., and Wiley D.C. Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid. Nature 333 (1988) 426-431